Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itacitinib + Ibrutinib in R/R DLBCL
NCT02760485Phase 2Completed
- Sponsor
- Incyte
- Start
- Dec 2016
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of itacitinib in diffuse large B-cell lymphoma (DLBCL), sponsored by Incyte. Started Dec 2016; status: completed.
02
Drugs
itacitinib
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT02760485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02760485.